Teva Pharmaceutical Industries Limited (TEVA) 43rd Annual J.P. Morgan Healthcare Conference (Transcript)

Company Overview - Teva Pharmaceutical Industries Limited is a global, profitable biopharmaceutical company with a growing and exciting innovative business [4] - The company has undergone significant changes under the leadership of CEO Richard Francis, who joined approximately two years ago [2][3] - Teva's strategy, referred to as the "Pivot to Growth," has been a key focus for employees worldwide, driving substantial transformation within the company [3] Leadership and Strategy - Richard Francis, President and CEO of Teva, has led the company through a period of significant change and improvement over the past two years [2][3] - The company's strategic focus on growth has been a major driver of its recent success, with employees globally aligning with this vision [3] Product Portfolio - Teva's innovative business includes key products such as AUSTEDO, AJOVY, and UZEDY, which are central to its growth strategy [4]